Skip to main content
NVDA+0.10%AAPL+0.03%MSFT+0.29%GOOGL+1.19%AMZN+0.25%TSM+2.95%SPCX+1.14%AVGO+4.00%TSLA+0.22%META-0.07%LLY+0.22%BRK-B-1.02%MU+1.33%SKHY+1.92%WMT-0.81%AMD+5.45%JPM+0.52%V-0.57%XOM-2.53%JNJ+0.91%ASMLa+2.80%MA-0.59%ABBV-0.10%INTC+3.61%1398.HK-0.39%CVX-1.59%0700.HK+0.86%COST-1.30%CSCO+1.03%ORCL+3.55%KO-1.64%PG-0.45%UNH-0.08%BAC+0.32%1816.HK-28.73%3988.HK-0.29%CAT+3.06%DELL+7.38%HD-0.28%0857.HK-1.09%PM+0.37%AP2d+2.18%AMAT+2.15%0939.HK-0.58%GE+3.20%1288.HK+0.11%LRCX+1.41%NVS+1.98%0005.HK+2.49%MS+1.91%AUDNZD+1.56%NZDUSD-1.52%NZDMXN-1.18%NZDSGD-1.17%NZDCAD-1.13%GBPNZD+1.03%NZDCHF-0.98%NZDJPY-0.88%EURNZD+0.84%EURAUD-0.70%AUDJPY+0.68%EURUSD-0.68%USDJPY+0.65%AUDCHF+0.59%USDCHF+0.55%GBPAUD-0.54%GBPUSD-0.51%AUDCAD+0.43%GBPTRY+0.41%USDCAD+0.41%GBPHKD+0.32%GBPMXN-0.28%USDTRY+0.27%EURCAD-0.26%CADJPY+0.26%AUDSGD+0.18%USDTHB+0.16%USDILS+0.16%EURGBP-0.16%CHFNOK-0.15%AUDDKK+0.15%EURCHF-0.15%CADCHF+0.15%EURZAR+0.14%USDNOK-0.13%GBPJPY+0.13%GBPCAD-0.13%USDZAR+0.12%CHFSEK-0.12%GBPZAR+0.12%CHFJPY+0.12%EURNOK-0.10%USDSEK-0.09%NOKJPY+0.08%PLNJPY-0.07%SGDJPY-0.07%EURSEK-0.06%AUDNOK+0.04%EURSGD+0.04%EURCNH+0.04%EURPLN+0.04%USDCOP-0.04%USDHKD+0.04%AUDUSD+0.03%EURHKD+0.03%USDDKK-0.02%USDPLN+0.02%GBPCHF+0.02%USDCNH-0.02%EURJPY-0.02%USDSGD+0.01%GBPSGD+0.01%CHFSGD-0.01%USDMXN+0.01%EURDKK0.00%EURCZK0.00%USOIL+0.82%UKOIL+0.71%GAGUSD-0.49%XAGUSD-0.49%XNGUSD+0.36%XAUUSD-0.29%GAUUSD-0.29%XPTUSD-0.24%HG1-0.13%COTTON-0.11%S1+0.10%W1+0.09%BTCUSD+1.09%ETHUSD+23.96%USDTUSD-0.01%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT+0.70%ZECUSDT+6.62%DOGEUSD+20.65%XMRUSDT+0.92%LINKUSD+25.58%BCHUSDT+5.72%XLMUSD+1.51%UNIUSD-0.24%LTCUSD+17.89%SUIUSD+2.31%HBARUSDT-0.65%TONUSD+41.71%TAOUSDT+2.76%AAVEUSD-0.64%DOTUSDT-0.79%ICPUSDT-0.76%ONDOUSDT+1.09%WLDUSDT+0.83%ARBUSDT+0.50%JUPUSDT+1.02%ATOMUSDT+0.71%INJUSDT-1.37%STXUSDT-1.40%TIAUSDT-2.34%FETUSDT+4.47%PYTHUSDT-2.47%SEIUSDT+2.45%IMXUSDT+0.79%GRTUSDT+1.53%OPUSDT+0.70%WIFUSDT+0.50%IOTAUSDT+1.57%POLUSDT+1.42%AXSUSDT+1.56%EOSUSDT+2.21%FARTCOINUSDT+3.71%DYDXUSDT+2.66%GALAUSDT+2.14%ORDIUSDT+3.33%RONINUSDT+1.89%NOTUSDT+4.64%NVDA+0.10%AAPL+0.03%MSFT+0.29%GOOGL+1.19%AMZN+0.25%TSM+2.95%SPCX+1.14%AVGO+4.00%TSLA+0.22%META-0.07%LLY+0.22%BRK-B-1.02%MU+1.33%SKHY+1.92%WMT-0.81%AMD+5.45%JPM+0.52%V-0.57%XOM-2.53%JNJ+0.91%ASMLa+2.80%MA-0.59%ABBV-0.10%INTC+3.61%1398.HK-0.39%CVX-1.59%0700.HK+0.86%COST-1.30%CSCO+1.03%ORCL+3.55%KO-1.64%PG-0.45%UNH-0.08%BAC+0.32%1816.HK-28.73%3988.HK-0.29%CAT+3.06%DELL+7.38%HD-0.28%0857.HK-1.09%PM+0.37%AP2d+2.18%AMAT+2.15%0939.HK-0.58%GE+3.20%1288.HK+0.11%LRCX+1.41%NVS+1.98%0005.HK+2.49%MS+1.91%AUDNZD+1.56%NZDUSD-1.52%NZDMXN-1.18%NZDSGD-1.17%NZDCAD-1.13%GBPNZD+1.03%NZDCHF-0.98%NZDJPY-0.88%EURNZD+0.84%EURAUD-0.70%AUDJPY+0.68%EURUSD-0.68%USDJPY+0.65%AUDCHF+0.59%USDCHF+0.55%GBPAUD-0.54%GBPUSD-0.51%AUDCAD+0.43%GBPTRY+0.41%USDCAD+0.41%GBPHKD+0.32%GBPMXN-0.28%USDTRY+0.27%EURCAD-0.26%CADJPY+0.26%AUDSGD+0.18%USDTHB+0.16%USDILS+0.16%EURGBP-0.16%CHFNOK-0.15%AUDDKK+0.15%EURCHF-0.15%CADCHF+0.15%EURZAR+0.14%USDNOK-0.13%GBPJPY+0.13%GBPCAD-0.13%USDZAR+0.12%CHFSEK-0.12%GBPZAR+0.12%CHFJPY+0.12%EURNOK-0.10%USDSEK-0.09%NOKJPY+0.08%PLNJPY-0.07%SGDJPY-0.07%EURSEK-0.06%AUDNOK+0.04%EURSGD+0.04%EURCNH+0.04%EURPLN+0.04%USDCOP-0.04%USDHKD+0.04%AUDUSD+0.03%EURHKD+0.03%USDDKK-0.02%USDPLN+0.02%GBPCHF+0.02%USDCNH-0.02%EURJPY-0.02%USDSGD+0.01%GBPSGD+0.01%CHFSGD-0.01%USDMXN+0.01%EURDKK0.00%EURCZK0.00%USOIL+0.82%UKOIL+0.71%GAGUSD-0.49%XAGUSD-0.49%XNGUSD+0.36%XAUUSD-0.29%GAUUSD-0.29%XPTUSD-0.24%HG1-0.13%COTTON-0.11%S1+0.10%W1+0.09%BTCUSD+1.09%ETHUSD+23.96%USDTUSD-0.01%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT+0.70%ZECUSDT+6.62%DOGEUSD+20.65%XMRUSDT+0.92%LINKUSD+25.58%BCHUSDT+5.72%XLMUSD+1.51%UNIUSD-0.24%LTCUSD+17.89%SUIUSD+2.31%HBARUSDT-0.65%TONUSD+41.71%TAOUSDT+2.76%AAVEUSD-0.64%DOTUSDT-0.79%ICPUSDT-0.76%ONDOUSDT+1.09%WLDUSDT+0.83%ARBUSDT+0.50%JUPUSDT+1.02%ATOMUSDT+0.71%INJUSDT-1.37%STXUSDT-1.40%TIAUSDT-2.34%FETUSDT+4.47%PYTHUSDT-2.47%SEIUSDT+2.45%IMXUSDT+0.79%GRTUSDT+1.53%OPUSDT+0.70%WIFUSDT+0.50%IOTAUSDT+1.57%POLUSDT+1.42%AXSUSDT+1.56%EOSUSDT+2.21%FARTCOINUSDT+3.71%DYDXUSDT+2.66%GALAUSDT+2.14%ORDIUSDT+3.33%RONINUSDT+1.89%NOTUSDT+4.64%
GL

Glaukos Corporation (GKOS)

NYSE • Healthcare

$181.17
+$2.89 (+1.6%)
Market closed

Last close at October 27, 2026 at 20:00 UTC

Open$178
Day Range$176.68 - $185.86
Avg. Volume (3M)1M
Market Cap$10.6B
52 Week Range
$76.88$191.62
Next EarningsTodayOct 28, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$185.6M100%
Gross Profitminus cost of goods$151.5M82%

In plain terms: out of every $100 in revenue, Glaukos Corporation currently loses $10.

Fundamentals & Financials

Revenue (TTM)
$612.8M
Net Income (TTM)
-$188M
EPS (TTM)
-$3.25
ROA (TTM)
-20.43%
Current Ratio
5.04

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-27.3%Q1 2026-$0.28
+40.0%Q2 2026-$0.18
+33.5%Q3 2026-$0.14
Next

Oct 28

todayQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +33.5%

Glaukos beat expectations on both revenue and adjusted EPS in the second fiscal quarter of 2026, reported July 29, as revenue rose about 50% to about $185.6 million from about $124.1 million a year ago and beat the $150.9 million consensus by about 23%, while adjusted EPS of -$0.14 topped the -$0.21 estimate by about 34%. Gross margin came in near 82%, while operating margin was near -9% as operating income was negative about $17.3 million and net income was negative about $18.4 million, up about 7% from negative $19.7 million a year ago. Operating cash flow was about $14.8 million, and next-period consensus calls for EPS of -$0.16 on revenue of $156.0 million.

Next report — what to expect

Glaukos Corporation (GKOS) is set to report earnings on November 4, 2026. Wall Street expects EPS of -$0.095 on revenue of $167.9 million. For trailing context, revenue grew +49.5% year over year last quarter. GKOS has beaten EPS in 6 of 8 most recent quarters, making estimate comparisons a key focus.

View full earnings history

About Glaukos Corporation

Glaukos Corporation trades on the NYSE under GKOS and develops ophthalmic medical devices, centered on minimally invasive glaucoma products. Its FY2025 revenue was $507.4 million. The company sells iStent, iStent inject, and iStent inject W for use in cataract surgery and in treating mild-to-moderate open-angle glaucoma.

Name
Glaukos Corporation
CEO
Thomas William Burns
Website
www.glaukos.com
Industry
Healthcare
Year Founded
1998
Employees
1,094

Today's Snapshot

AI-generated

GKOS closed 1.6% above yesterday's close, while its sector was flat. Volume was about half as much again as its usual level.

Trading Volume

Above 10d avg 899.6K

1.3M

vs S&P 500 Today

Outperforming Market

+0.96%

Updated: October 27, 2026 at 20:13 UTC

Technical Indicators

6 Buy1 Neutral1 Sell
GKOS presents a bullish alignment across price and volume that underpins the buy rating, though trend strength reads as modest. The stock is trading above short- and longer-term moving averages and the pivot is beneath the current price, while MACD, CCI and momentum readings point to upward momentum and OBV confirms accumulation. RSI and volatility readings are elevated but not extreme, and ADX indicates a developing rather than a powerful trend. Taken together, momentum and price structure favor buyers with tempered trend conviction. Technical takeaway: Overall technicals support a buy stance.
All signals
  • EMA (5 indicators)$141.67 - $174.47
    Buy
  • RSI (14)64.52
    Neutral
  • Stochastic %K (14, 3, 3)92.02
    Sell
  • MACD Level (12, 26)3.19
    Buy

Peers & Related Assets

OCULOcular Therapeutix, Inc.
$6.72+3.9%
STAASTAAR Surgical Company
$24.16+4.0%
RXSTRxSight, Inc.
$4.9-0.6%
EYPTEyePoint Pharmaceuticals, Inc.
$0.36-0.7%
ALCAlcon Inc.
BLCOBausch + Lomb Corporation
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.